BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/06/2026

FDA Clears Protamine Sulfate Drug Products for Sale

The US Food and Drug Administration (FDA) has ruled that Protamine Sulfate drug products, including a 50mg/5mL solution, will not be withdrawn from sale due to safety or effectiveness concerns, allowing the FDA to continue approving Abbreviated New Drug Applications (ANDAs) for these products.

Source: Federal Register — Health and Human ServicesOpen original release →